NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Scientific & Technical Instruments · USD

Novanta Inc. (NOVT) Stock Analysis

Novanta Inc. (NOVT) is a Scientific & Technical Instruments stock listed on NASDAQ and quoted in US Dollar.

NOVT

$148.36

+$1.12 (+0.76%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NOVT with… →

NOVT Key Statistics

As of Sep 4, 2026
Trading
Open
$147.23
Previous Close
$147.24
Day's Range
147.10–149.88
52-Week Range
98.27–176.38
Volume
218.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.68
Valuation
Market Cap
$5.61B
P/E Ratio
93.90
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
33.98
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
5.45
EPS (ttm)Profit attributable to each share over the last twelve months.
1.58
Financials (FY)
Revenue (FY)
$980.60M+3.30%
Net Income (FY)
$53.83M−16.01%
Profit marginThe share of revenue left as profit after all costs and taxes.
6.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
37.82M
1-Year Return
+28.62%
Dividend and dates
Earnings Date
November 3, 2026estimated
Avg Volume
481.32K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NOVT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.68%
2025−22.11%
2024−9.29%
2023+23.95%
2022−22.95%
2021+49.15%
2020+33.67%
2019+40.38%
2018+26.00%
2017+138.10%
2016 (partial year)+29.71%

As of September 4, 2026.

NOVT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$980.60M$53.83M5.5%
2024$949.25M$64.09M6.8%
2023$881.66M$72.88M8.3%
2022$860.90M$74.05M8.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$980.60M$435.28M$116.66M$53.83M5.5%
2024$949.25M$421.55M$124.29M$64.09M6.8%
2023$881.66M$399.90M$123.31M$72.88M8.3%
2022$860.90M$378.47M$107.46M$74.05M8.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NOVT Valuation vs Scientific & Technical Instruments Median

Median of 35 stocks
MetricNOVTScientific & Technical Instruments medianvs median
P/E93.9039.15140% above
P/S ratio5.455.244% above
Profit margin6.00%2.42%3.6 pts above

Medians across 35 Scientific & Technical Instruments stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Novanta Inc. (NOVT) is capitalised at $5.61B on the latest close. It is classified in the Scientific & Technical Instruments industry, within the Technology sector. Headcount on file is 3,000.

Over the past 52 weeks the price has ranged from $98.27 to $176.38. The most recent close on file for NOVT is $148.36, dated September 4, 2026. That is +$1.12 (+0.76%) against the previous close. The latest close sits 50.97% above that 52-week low.

Financial Health

In fiscal 2025, Novanta Inc. reported revenue of $980.60M. Against the prior fiscal year total of $949.25M, that is a change of +3.30%. The same year closed with net income of $53.83M. That is −16.01% against the prior fiscal year. Profit margin runs at 6%. That is 3.6 percentage points above the Scientific & Technical Instruments median of 2.42%. Earnings per share on a trailing basis come to 1.58.

Across the 4 fiscal years on file, revenue moves from $860.90M in 2022 to $980.60M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

NOVT trades at a trailing price-to-earnings ratio of 93.9. That is 139.85% above the Scientific & Technical Instruments median of 39.15. The forward P/E on file is 33.98. Measured against sales, the shares trade at 5.45 times revenue. On price-to-sales that is 3.9% above the Scientific & Technical Instruments median of 5.24. 35 Scientific & Technical Instruments companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.68. Annualized volatility over the trailing 10 years is 39.56%. Over the trailing twelve months the price has returned +28.62%. Measured over 10 years, that is +24.19% a year compounded.

Growth & Income

No dividend is on file for NOVT.

So far in 2026 the price is +24.68%. The strongest complete calendar year on file is 2017 at +138.10%; the weakest is 2022 at −22.95%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Novanta Inc. (NOVT) operates in the Scientific & Technical Instruments industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Novanta Inc. NOVT $5.61B 93.9
Keysight Technologies, Inc. KEYS $55.71B 43.7
Coherent Corp. COHR $55.20B 64.1
Garmin Ltd. GRMN $53.43B 28.6

The Scientific & Technical Instruments industry average P/E ratio is 39.1x. Novanta Inc. trades at a P/E of 93.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Scientific & Technical Instruments Stocks

KEYS

Keysight Technologies, Inc.

$55.71B

 COHR

Coherent Corp.

$55.20B

 GRMN

Garmin Ltd.

$53.43B

 TDY

Teledyne Technologies Incorporated

$28.31B

 MKSI

MKS Inc.

$17.60B

 FTV

Fortive Corporation

$17.20B
View all Scientific & Technical Instruments stocks →

Popular Technology Stocks

NVDA

NVIDIA Corporation

$5.56T

 AAPL

Apple Inc.

$4.67T

 MSFT

Microsoft Corporation

$3.71T

 TSM

Taiwan Semiconductor Manufacturing Company Limited

$2.22T

 AVGO

Broadcom Inc.

$1.70T
View all Technology stocks →

About Novanta Inc.

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Visit website →